An anti-bacterial cleaning agent has been confirmed to nearly eradicate the hospital super-bug MRSA in a recent study.
Byotrol cleaning compound used on door handles, bed rails, patient contact systems and other surfaces lowered levels of MRSA by 75 per cent during the first major trial conducted at Glasgow Royal Infirmary.
Hospital infections received after surgery in Scotland killed 300 people during 2004 and similar infections steal 380,000 bed days a year.
England has more than 60,000 cases of Staphylococcal infections each year, costing £200 million every year, according to figures from the National Audit Office.
The independent study, by University of Glasgow professor Curtis Gemmell, monitored the bug versus disinfectant battle in Byotrol and said the agent was found to leave a residual paint on surfaces that prevent attachment to surfaces before the chemical agents kill them outright.
Byotrol's deputy chairman Stephen Falder said the results were typical and he was pleased with the research study.
"This independent study has demonstrated the outstanding effectiveness of Byotrol in a working hospital environment," he said.